Alveolar Cleft Repair Using Osteoinductive Ceramics
ACROSTIC
1 other identifier
interventional
60
1 country
4
Brief Summary
In this study, patients with unilateral cleft lip and palate are enrolled in a multicenter stepped wedge randomized trial ithat compares alveolar cleft closure using autologous bone harvested form the mandibular symphysis with an osteoinductive biphasic calcium phosphate putty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2022
CompletedFirst Posted
Study publicly available on registry
April 15, 2022
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedDecember 6, 2023
November 1, 2023
2.7 years
April 11, 2022
November 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone volume
One year postoperative residual bone volume
1 year postoperatively
Secondary Outcomes (2)
Postoperative pain
Day 1 to 7 postoperatively
Canine eruption
1 year postoperatively
Study Arms (2)
Alveolar cleft repair using autologous bone from the mandibular symphysis
OTHERControl group
Alveolar cleft repair using a biphasic clacium phosphate putty
OTHERStudy group
Interventions
Early secondary alveolar cleft repair is performed in children with a unilateral alveolar cleft using eirther autologous bone or a calcium phosphate based putty
Eligibility Criteria
You may qualify if:
- unilateral alveolar cleft, early secondary alveolar cleft closure
You may not qualify if:
- cleft lip and palate in a syndromic context
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UMC Utrechtlead
- Radboud University Medical Centercollaborator
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)collaborator
- Academisch Ziekenhuis Groningencollaborator
- Medisch Centrum Leeuwardencollaborator
Study Sites (4)
Amsterdam UMC
Amsterdam, Netherlands
UMC Groningen
Groningen, Netherlands
Radboud UMC
Nijmegen, Netherlands
UMC Utrecht
Utrecht, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nard Janssen, MD, DDS, PhD
UMC Utrecht
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- N.G. Janssen, Prinicpal Investigator
Study Record Dates
First Submitted
April 11, 2022
First Posted
April 15, 2022
Study Start
June 1, 2022
Primary Completion
February 1, 2025
Study Completion
February 1, 2025
Last Updated
December 6, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share